fig3

The predictive role of hematologic indicators in locally advanced esophageal squamous cell carcinoma patients receiving neoadjuvant chemoimmunotherapy

Figure 3. ROC curve analysis of baseline and preoperative hematologic indicators. (A) ROC curve analysis of baseline hematologic indicators. (B) ROC curve analysis of preoperative hematologic indicators. ROC: Receiver operating characteristic; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; LMR: lymphocyte-to-monocyte ratio; CAR: C-reactive protein-to-albumin ratio.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/